- Published at
- by marketscreener.com
neutral
neutral
Onconova Therapeutics?: Proxy Statement Mar 04, 2021
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy... | March 4, 2021